1. Home
  2. MDXG vs VTS Comparison

MDXG vs VTS Comparison

Compare MDXG & VTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • VTS
  • Stock Information
  • Founded
  • MDXG 2006
  • VTS 2014
  • Country
  • MDXG United States
  • VTS United States
  • Employees
  • MDXG N/A
  • VTS N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • VTS Oil & Gas Production
  • Sector
  • MDXG Health Care
  • VTS Energy
  • Exchange
  • MDXG Nasdaq
  • VTS Nasdaq
  • Market Cap
  • MDXG 1.1B
  • VTS 937.5M
  • IPO Year
  • MDXG N/A
  • VTS N/A
  • Fundamental
  • Price
  • MDXG $6.94
  • VTS $24.42
  • Analyst Decision
  • MDXG Buy
  • VTS Strong Buy
  • Analyst Count
  • MDXG 1
  • VTS 4
  • Target Price
  • MDXG $12.00
  • VTS $30.25
  • AVG Volume (30 Days)
  • MDXG 439.7K
  • VTS 362.8K
  • Earning Date
  • MDXG 10-29-2025
  • VTS 11-03-2025
  • Dividend Yield
  • MDXG N/A
  • VTS 9.18%
  • EPS Growth
  • MDXG N/A
  • VTS 27.28
  • EPS
  • MDXG 0.21
  • VTS 1.12
  • Revenue
  • MDXG $363,774,000.00
  • VTS $239,904,000.00
  • Revenue This Year
  • MDXG $12.68
  • VTS $28.41
  • Revenue Next Year
  • MDXG $8.18
  • VTS N/A
  • P/E Ratio
  • MDXG $32.78
  • VTS $21.96
  • Revenue Growth
  • MDXG 6.85
  • VTS 4.55
  • 52 Week Low
  • MDXG $5.47
  • VTS $18.90
  • 52 Week High
  • MDXG $10.14
  • VTS $28.41
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 46.17
  • VTS 41.23
  • Support Level
  • MDXG $6.89
  • VTS $23.89
  • Resistance Level
  • MDXG $7.14
  • VTS $26.13
  • Average True Range (ATR)
  • MDXG 0.18
  • VTS 0.55
  • MACD
  • MDXG -0.04
  • VTS -0.26
  • Stochastic Oscillator
  • MDXG 29.55
  • VTS 17.10

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About VTS Vitesse Energy Inc.

Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.

Share on Social Networks: